Deutsche Bank’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Deutsche Bank’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-418	Closed	-$7K	–	6131
2014 Q4	$7K	Sell	418 -882	-68%	-$12.8K	﹤0.01%	5805
2014 Q3	$17K	Sell	1,300 -100	-7%	-$1.19K	﹤0.01%	5251
2014 Q2	$17K	Buy	1,400 +400	+40%	+$4.17K	﹤0.01%	5369
2014 Q1	$1K	Buy	+1,000	New	+$13.4K	﹤0.01%	5503

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Deutsche Bank's INFI Position: Q2 2022 in Review

Deutsche Bank sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2022, closing a stake of 52,999 shares — an estimated $60K sold.

Deutsche Bank first reported a position in INFI in Q2 2013 and held it in 25 quarters. The position peaked at $9.39M in Q4 2013. 77 funds tracked by Wall St. Rank hold INFI as of Q2 2022.

Deutsche Bank reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
Deutsche Bank sold 52,999 Infinity Pharmaceuticals, Inc. shares in Q2 2022, an estimated $60K.
Deutsche Bank first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 25 quarters.
Deutsche Bank's Infinity Pharmaceuticals, Inc. position peaked at $9.39M in Q4 2013.
77 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.